Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Amyloidosis, advanced glycation end products and Alzheimer disease — Mark A. Smith (1995) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Amyloidosis, advanced glycation end products and Alzheimer disease
Shared by
George Perry
Amyloidosis, advanced glycation end products and Alzheimer disease
Letter
1995
en
Authors
+1 more
MS
Mark A. Smith
VM
Vincent M. Monnier
LS
Lawrence M. Sayre
Abstract
1 min read
Smith, Mark A.; Monnier, Vincent M.; Sayre, Lawrence M.; Perry, George Author Information
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Signal Transduction in Alzheimer’s Disease
Mark A. Smith
,
Xiongwei Zhu
,
George Perry
Article
1988
CELL BIOLOGY OF NEURONS IN ALZHEIMER AND OTHER DEGENERATIVE DISEASES
George Perry
,
Valeria Manetto
,
Paul Mulvihill
,
Michelle Onorato
,
Massimo Tabaton
,
L. Autilio‐Gambetti
,
Pierluigi Gambetti
Article
1997
Mechanisms of Neurotoxicity Associated with Amyloid β Deposition and the Role of Free Radicals in the Pathogenesis of Alzheimer's Disease: A Critical Appraisal
Lawrence M. Sayre
,
Michael G. Zagorski
,
Witold K. Surewicz
,
Grant A. Krafft
,
George Perry
Article
2004
DOPAMINE DOES NOT IMPAIRE VENTILATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
B. Najem
,
Agnieszka Ciarka
,
R. Rimacchi
,
Jean Louis Vincent
,
Sonia Velez‐Roa
,
M. Dumonceaux
,
Marc Leeman
,
Philippe van de Borne
Article
2018
Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
Chung‐Jung Chiu
,
Naila Rabbani
,
Sheldon Rowan
,
Min‐Lee Chang
,
Sherilyn J. Sawyer
,
Frank B Hu
,
Walter C. Willett
,
Paul J. Thornalley
,
Attia Anwar
,
Liliana Bar
,
Jae H. Kang
,
Allen Taylor
Discussion(0)
No comments yet. Be the first to comment.